Kerkau T - Search Results

1

Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.

Beyersdorf N, Hanke T, Kerkau T, Hünig T. Beyersdorf N, et al. Among authors: kerkau t. Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv91-5. doi: 10.1136/ard.2005.042564. Ann Rheum Dis. 2005. PMID: 16239397 Free PMC article. Review.

2

Early phenotypic and functional alterations in lymphocytes from simian immunodeficiency virus infected macaques.

Kneitz C, Kerkau T, Müller J, Coulibaly C, Stahl-Hennig C, Hunsmann G, Hünig T, Schimpl A. Kneitz C, et al. Among authors: kerkau t. Vet Immunol Immunopathol. 1993 Apr;36(3):239-55. doi: 10.1016/0165-2427(93)90022-v. Vet Immunol Immunopathol. 1993. PMID: 8506614 Free article.

3

The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules.

Kerkau T, Bacik I, Bennink JR, Yewdell JW, Húnig T, Schimpl A, Schubert U. Kerkau T, et al. J Exp Med. 1997 Apr 7;185(7):1295-305. doi: 10.1084/jem.185.7.1295. J Exp Med. 1997. PMID: 9104816 Free PMC article.

4

Impaired thymopoietic potential of immature CD3(-)CD4(+)CD8(-) T cell precursors from SIV-infected rhesus monkeys.

Neben K, Heidbreder M, Müller J, Marxer A, Petry H, Didier A, Schimpl A, Hünig T, Kerkau T. Neben K, et al. Among authors: kerkau t. Int Immunol. 1999 Sep;11(9):1509-18. doi: 10.1093/intimm/11.9.1509. Int Immunol. 1999. PMID: 10464172

5

HIV type 1 abrogates TAP-mediated transport of antigenic peptides presented by MHC class I. Transporter associated with antigen presentation.

Kutsch O, Vey T, Kerkau T, Hünig T, Schimpl A. Kutsch O, et al. Among authors: kerkau t. AIDS Res Hum Retroviruses. 2002 Nov 20;18(17):1319-25. doi: 10.1089/088922202320886361. AIDS Res Hum Retroviruses. 2002. PMID: 12487820

6

Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists.

Lühder F, Huang Y, Dennehy KM, Guntermann C, Müller I, Winkler E, Kerkau T, Ikemizu S, Davis SJ, Hanke T, Hünig T. Lühder F, et al. Among authors: kerkau t. J Exp Med. 2003 Apr 21;197(8):955-66. doi: 10.1084/jem.20021024. J Exp Med. 2003. PMID: 12707299 Free PMC article.

7

Rapid recovery from T lymphopenia by CD28 superagonist therapy.

Elflein K, Rodriguez-Palmero M, Kerkau T, Hünig T. Elflein K, et al. Among authors: kerkau t. Blood. 2003 Sep 1;102(5):1764-70. doi: 10.1182/blood-2002-11-3586. Epub 2003 May 15. Blood. 2003. PMID: 12750179 Free article.

8

Selective loss of regulatory T cells in thymomas.

Ströbel P, Rosenwald A, Beyersdorf N, Kerkau T, Elert O, Murumägi A, Sillanpää N, Peterson P, Hummel V, Rieckmann P, Burek C, Schalke B, Nix W, Kiefer R, Müller-Hermelink HK, Marx A. Ströbel P, et al. Among authors: kerkau t. Ann Neurol. 2004 Dec;56(6):901-4. doi: 10.1002/ana.20340. Ann Neurol. 2004. PMID: 15562414

9

Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.

Beyersdorf N, Gaupp S, Balbach K, Schmidt J, Toyka KV, Lin CH, Hanke T, Hünig T, Kerkau T, Gold R. Beyersdorf N, et al. Among authors: kerkau t. J Exp Med. 2005 Aug 1;202(3):445-55. doi: 10.1084/jem.20051060. J Exp Med. 2005. PMID: 16061730 Free PMC article.

10

CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.

Beyersdorf N, Hanke T, Kerkau T, Hünig T. Beyersdorf N, et al. Among authors: kerkau t. Autoimmun Rev. 2006 Jan;5(1):40-5. doi: 10.1016/j.autrev.2005.06.001. Epub 2005 Jul 7. Autoimmun Rev. 2006. PMID: 16338210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters